Informational purposes only, not investment advice.
InflaRx N.V. (IFRX)
tormere.com/research/IFRX · generated 2026-11-07
$1.30
-3.69%
General Information
Price$1.30
Change-3.69%
Market Cap—
SectorHealth Care
IndustryBiotechnology
ExchangeNasdaq
Beta (raw, 60mo vs SPY)2.37
Signals
Insider Velocity—
Congress Trades (90d)—
Short Volume
70% of daily vol
Conviction Score—
Price Chart (1 Year)
Recent News
One 30 mg dose of InflaRx’s drug blocked over 90% of an inflammatory signal in a blood test. — Stock Titan · 2026-11-06
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan — Yahoo Finance · 2026-11-06
InflaRx Targets Kidney Protection, Steroid Reduction in AAV With Izicopan Trials — Yahoo Finance · 2026-11-03
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day — Stock Titan · 2026-11-03
Tormere — informational purposes only, not investment advice.
